| For: | Afrin LB, Molderings GJ. A concise, practical guide to diagnostic assessment for mast cell activation disease. World J Hematol 2014; 3(1): 1-17 [DOI: 10.5315/wjh.v3.i1] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6204/full/v3/i1/1.htm |
| Number | Citing Articles |
| 1 |
Suranjith L. Seneviratne, Anne Maitland, Lawrence Afrin. Mast cell disorders in Ehlers–Danlos syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2017; 175(1) doi: 10.1002/ajmg.c.31555
|
| 2 |
Milda Vysniauskaite, Hans-Jörg Hertfelder, Johannes Oldenburg, Peter Dreßen, Stefan Brettner, Jürgen Homann, Gerhard J. Molderings, Kottarappat N Dileepan. Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease. PLOS ONE 2015; 10(4) doi: 10.1371/journal.pone.0124912
|
| 3 |
Lawrence B. Afrin, Sally Self, Jeremiah Menk, John Lazarchick. Characterization of Mast Cell Activation Syndrome. The American Journal of the Medical Sciences 2017; 353(3) doi: 10.1016/j.amjms.2016.12.013
|
| 4 |
B. Sido, J. Homann, H.-J. Hertfelder, T. Zienkiewicz, K.-P. Christians, P. Schablin, M. Mücke, G. J. Molderings. Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung. Der Chirurg 2019; 90(7) doi: 10.1007/s00104-019-0935-z
|
| 5 |
Betsy Selleck, Cynthia Selleck. A Primer on Mast Cell Activation Disease for the Nurse Practitioner. The Journal for Nurse Practitioners 2021; 17(7) doi: 10.1016/j.nurpra.2021.04.015
|
| 6 |
Karina Sturm, Helena Jung, Andrea Maier. Ratgeber Ehlers-Danlos-Syndrome. 2022; doi: 10.1007/978-3-662-65041-7_3
|
| 7 |
Gerhard J. Molderings, Britta Haenisch, Stefan Brettner, Jürgen Homann, Markus Menzen, Franz Ludwig Dumoulin, Jens Panse, Joseph Butterfield, Lawrence B. Afrin. Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(7) doi: 10.1007/s00210-016-1247-1
|
| 8 |
Gerhard J. Molderings. The genetic basis of mast cell activation disease - looking through a glass darkly. Critical Reviews in Oncology/Hematology 2015; 93(2) doi: 10.1016/j.critrevonc.2014.09.001
|
| 9 |
Lawrence B. Afrin, Alexander Khoruts. Mast Cell Activation Disease and Microbiotic Interactions. Clinical Therapeutics 2015; 37(5) doi: 10.1016/j.clinthera.2015.02.008
|
| 10 |
Soumya Arun, Abbie Storan, Bethan Myers. Mast cell activation syndrome and the link with long COVID. British Journal of Hospital Medicine 2022; 83(7) doi: 10.12968/hmed.2022.0123
|
| 11 |
Raymond F. Palmer, Tania T. Dempsey, Lawrence B. Afrin. Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity. Journal of Xenobiotics 2023; 13(4) doi: 10.3390/jox13040045
|
| 12 |
Craig Friesen, Meenal Singh, Vivekanand Singh, Jennifer V. Schurman. An observational study of headaches in children and adolescents with functional abdominal pain. Medicine 2018; 97(30) doi: 10.1097/MD.0000000000011395
|
| 13 |
Lawrence B. Afrin, Joseph H. Butterfield, Martin Raithel, Gerhard J. Molderings. Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic options. Annals of Medicine 2016; 48(3) doi: 10.3109/07853890.2016.1161231
|
| 14 |
Lawrence B. Afrin, Tania T. Dempsey, Leonard B. Weinstock. Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?. Vaccines 2022; 10(1) doi: 10.3390/vaccines10010127
|
| 15 |
Lawrence B. Afrin. Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease. The American Journal of the Medical Sciences 2014; 348(6) doi: 10.1097/MAJ.0000000000000325
|
| 16 |
Theoharis C. Theoharides, Irene Tsilioni, Huali Ren. Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?. Expert Review of Clinical Immunology 2019; 15(6) doi: 10.1080/1744666X.2019.1596800
|
| 17 |
|
| 18 |
Shanda R. Dorff, Lawrence B. Afrin. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review. Journal of Obstetrics and Gynaecology 2020; 40(7) doi: 10.1080/01443615.2019.1674259
|
| 19 |
Anupam Aich, Lawrence Afrin, Kalpna Gupta. Mast Cell-Mediated Mechanisms of Nociception. International Journal of Molecular Sciences 2015; 16(12) doi: 10.3390/ijms161226151
|
| 20 |
Susan J. Allen, Paul L. Chazot, C. Jane Dixon. CanH2‐receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19‐year‐old female? A case report. British Journal of Clinical Pharmacology 2018; 84(7) doi: 10.1111/bcp.13578
|
| 21 |
Peter C. Rowe. Principles and Practice of Pediatric Infectious Diseases. 2023; doi: 10.1016/B978-0-323-75608-2.00200-7
|
| 22 |
Visha K. Tailor, Ellen Morris, Alka A. Bhide, Ruwan Fernando, Guiseppe A. Digesu, Vik Khullar. Does cystoscopy method affect the investigation of bladder pain syndrome/interstitial cystitis?. International Urogynecology Journal 2021; 32(5) doi: 10.1007/s00192-020-04512-0
|
| 23 |
Pradeep Chopra, Linda Bluestein. Perioperative Care in Patients with Ehlers Danlos Syndromes. Open Journal of Anesthesiology 2020; 10(01) doi: 10.4236/ojanes.2020.101002
|
| 24 |
Lawrence B. Afrin, Dieter Pöhlau, Martin Raithel, Britta Haenisch, Franz L. Dumoulin, Juergen Homann, Uwe M. Mauer, Sabrina Harzer, Gerhard J. Molderings. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity 2015; 50 doi: 10.1016/j.bbi.2015.07.002
|
| 25 |
|
| 26 |
Lawrence B. Afrin, Svetlana Blitshteyn, Linda S. Bluestein, Tania T. Dempsey, Andrew J. Maxwell, Claudia S. Miller, Èva Nagy, Diane J. Nugent, Jill R. Schofield, Leonard B. Weinstock, Shijun Cindy Xi, Gerhard J. Molderings. Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years. Diagnosis 2026; doi: 10.1515/dx-2026-0016
|
| 27 |
Lawrence B. Afrin, Tania T. Dempsey, Lila S. Rosenthal, Shanda R. Dorff. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding. Journal of Obstetrics and Gynaecology 2019; 39(5) doi: 10.1080/01443615.2018.1550475
|
| 28 |
Leonard B. Weinstock, Andrew W. Campbell, Luke Curtis, Jordan Gutovich. Mycotoxin-Triggered Attacks of Nausea, Vomiting, and Abdominal Pain and Episodes of Pseudo-Obstruction. Universal Library of Medical and Health Sciences 2024; 2(01) doi: 10.70315/uloap.ulmhs.2024.0201008
|
| 29 |
Lawrence B. Afrin. Mast cell activation disease and the modern epidemic of chronic inflammatory disease. Translational Research 2016; 174 doi: 10.1016/j.trsl.2016.01.003
|
| 30 |
G. Simpson. Menstrual anaphylactoid reactions and presumed systemic mast cell activation syndrome. Internal Medicine Journal 2016; 46(7) doi: 10.1111/imj.13077
|
| 31 |
Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International Journal of Infectious Diseases 2020; 100 doi: 10.1016/j.ijid.2020.09.016
|
| 32 |
Tinus Häder, Gerhard J. Molderings, Frank Klawonn, Rupert Conrad, Martin Mücke, Julia Sellin. Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold. Digestive Diseases and Sciences 2023; 68(8) doi: 10.1007/s10620-023-07921-5
|
| 33 |
Nevio Cimolai. Mast Cell Biology and Linkages for Non-clonal Mast Cell Activation and Autoimmune/Inflammatory Syndrome Induced by Adjuvants. SN Comprehensive Clinical Medicine 2020; 2(11) doi: 10.1007/s42399-020-00494-8
|
| 34 |
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, Joseph H. Brewer, Jill B. Brook, Ariana D. Buchanan, Jill R. Cuni, William P. Davey, Tania T. Dempsey, Shanda R. Dorff, Martin S. Dubravec, Alena G. Guggenheim, Kimberly J. Hindman, Bruce Hoffman, David L. Kaufman, Stephanie J. Kratzer, Theodore M. Lee, Mindy S. Marantz, Andrew J. Maxwell, Kelly K. McCann, Dwight L. McKee, Laurie Menk Otto, Laura A. Pace, Dahra D. Perkins, Laurie Radovsky, Mary S. Raleigh, Sonia A. Rapaport, Emma J. Reinhold, Mark L. Renneker, William A. Robinson, Aaron M. Roland, E. Scott Rosenbloom, Peter C. Rowe, Ilene S. Ruhoy, David S. Saperstein, David A. Schlosser, Jill R. Schofield, Janet E. Settle, Leonard B. Weinstock, Martina Wengenroth, Mark Westaway, Shijun Cindy Xi, Gerhard J. Molderings. Diagnosis of mast cell activation syndrome: a global “consensus-2”. Diagnosis 2021; 8(2) doi: 10.1515/dx-2020-0005
|
| 35 |
Gerhard J. Molderings. Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features. Translational Research 2016; 174 doi: 10.1016/j.trsl.2016.01.001
|